MicroRNA-181 Functions as an Antioncogene and Mediates NF-κB Pathway by Targeting RTKN2 in Ovarian Cancers
Authors:
- 11 October 2018
- journal article
- research article
- Published by Springer Nature in Reproductive Sciences
- Vol. 26 (8) , 1071-1081
Abstract
MicroRNA (miR)-181 has been reported to participate in carcinogenesis and tumor progression in several malignant cancers, but its expression and biological functions in ovarian cancer have remained largely unclarified. Here, we first measured miR-181 expression in clinical ovarian cancers and found the expression levels of miR-181 were significantly lower in ovarian cancer tissues than that in adjacent tissues. Next, we screened and identified a direct miR-181 target, Rhotekin2 (RTKN2). A correlation between miR-181 and RTKN2 expression was also confirmed in clinical samples of ovarian cancers. Upregulation of miR-181 would specifically and markedly suppress RTKN2 expression. The miR-181-overexpressing subclones showed significant cell growth inhibition by cell apoptosis induction and significant impairment of cell invasiveness in SKOV3 and HO8910 ovarian cancer cells. To identify the mechanisms, we investigated the NF-κB pathway and found that nuclear factor-kappa B (NF-κB), B-cell lymphoma-2 (Bcl-2), and vascular endothelial growth factor (VEGF) were suppressed, whereas IκBα was promoted in miR-181-overexpressing cells. These findings indicate that miR-181 functions as a tumor suppressor and plays a substantial role in inhibiting the tumorigenesis and reversing the metastasis of ovarian cancer through RTKN2-NF-κB signaling pathway in vitro. Taken together, we believe that miR-181 may be a promising therapeutic target for treating malignant ovarian cancers.Keywords
This publication has 25 references indexed in Scilit:
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysisGynecologic Oncology, 2013
- Knockdown of RLIP76 expression by RNA interference inhibits invasion, induces cell cycle arrest, and increases chemosensitivity to the anticancer drug temozolomide in glioma cellsJournal of Neuro-Oncology, 2013
- TGF-β upregulates miR-181a expression to promote breast cancer metastasisJournal of Clinical Investigation, 2012
- Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in JapanesePLOS Genetics, 2012
- miR-181 targets multiple Bcl-2 family members and influences apoptosis and mitochondrial function in astrocytesMitochondrion, 2012
- MiR-181b suppresses proliferation of and reduces chemoresistance to temozolomide in U87 glioma stem cellsJournal of Biomedical Research, 2010
- Nuclear factor κB transcription factors are coexpressed and convey a poor outcome in ovarian cancerCancer, 2010
- Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaBJournal of Ovarian Research, 2008
- Rho/Rhotekin-mediated NF-κB activation confers resistance to apoptosisOncogene, 2004
- Inhibition of NF-κB Activity Decreases the VEGF mRNA Expression in MDA-MB-231 Breast Cancer CellsBreast Cancer Research and Treatment, 2002